Logo image of CSOD

Cornerstone Ondemand (CSOD) Stock Fundamental Analysis

NASDAQ:CSOD - Nasdaq -

57.49  +0.01 (+0.02%)

After market: 57.51 +0.02 (+0.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CSOD. CSOD was compared to 281 industry peers in the Software industry. CSOD may be in some trouble as it scores bad on both profitability and health. CSOD shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CSOD had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 2.83%
PM (TTM) -3.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CSOD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CSOD has an Altman-Z score of 1.08. This is a bad value and indicates that CSOD is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 3.45 is on the high side and indicates that CSOD has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 3.45
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.68 indicates that CSOD may have some problems paying its short term obligations.
A Quick Ratio of 0.68 indicates that CSOD may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.32% over the past year.
Measured over the past years, CSOD shows a very strong growth in Earnings Per Share. The EPS has been growing by 100.57% on average per year.
CSOD shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.95%.
Measured over the past years, CSOD shows a quite strong growth in Revenue. The Revenue has been growing by 16.88% on average per year.
EPS 1Y (TTM)88.32%
EPS 3Y63.13%
EPS 5Y100.57%
EPS Q2Q%82.5%
Revenue 1Y (TTM)31.95%
Revenue growth 3Y15.41%
Revenue growth 5Y16.88%
Sales Q2Q%16.26%

3.2 Future

CSOD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.25% yearly.
Based on estimates for the next years, CSOD will show a quite strong growth in Revenue. The Revenue will grow by 9.48% on average per year.
EPS Next Y43.2%
EPS Next 2Y24.04%
EPS Next 3Y15.52%
EPS Next 5Y10.25%
Revenue Next Year18.09%
Revenue Next 2Y12.63%
Revenue Next 3Y11.24%
Revenue Next 5Y9.48%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSOD Yearly Revenue VS EstimatesCSOD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CSOD Yearly EPS VS EstimatesCSOD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

CSOD is valuated rather expensively with a Price/Earnings ratio of 22.28.
When comparing the Price/Earnings ratio of CSOD to the average of the S&P500 Index (28.87), we can say CSOD is valued slightly cheaper.
With a Price/Forward Earnings ratio of 20.99, CSOD is valued on the expensive side.
CSOD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 22.28
Fwd PE 20.99
CSOD Price Earnings VS Forward Price EarningsCSOD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.92
CSOD Per share dataCSOD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CSOD's earnings are expected to grow with 15.52% in the coming years.
PEG (NY)0.52
PEG (5Y)0.22
EPS Next 2Y24.04%
EPS Next 3Y15.52%

0

5. Dividend

5.1 Amount

CSOD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Cornerstone Ondemand

NASDAQ:CSOD (10/14/2021, 8:39:27 PM)

After market: 57.51 +0.02 (+0.03%)

57.49

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)03-01 2022-03-01/amc
Inst Owners0.76%
Inst Owner Change0%
Ins Owners2.1%
Ins Owner Change0%
Market Cap3.84B
Analysts70
Price Target61.3 (6.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.28
Fwd PE 20.99
P/S 4.62
P/FCF N/A
P/OCF N/A
P/B 12.44
P/tB N/A
EV/EBITDA 25.92
EPS(TTM)2.58
EY4.49%
EPS(NY)2.74
Fwd EY4.76%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.43
BVpS4.62
TBVpSN/A
PEG (NY)0.52
PEG (5Y)0.22
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 2.83%
PM (TTM) -3.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 3.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 1.08
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.32%
EPS 3Y63.13%
EPS 5Y100.57%
EPS Q2Q%82.5%
EPS Next Y43.2%
EPS Next 2Y24.04%
EPS Next 3Y15.52%
EPS Next 5Y10.25%
Revenue 1Y (TTM)31.95%
Revenue growth 3Y15.41%
Revenue growth 5Y16.88%
Sales Q2Q%16.26%
Revenue Next Year18.09%
Revenue Next 2Y12.63%
Revenue Next 3Y11.24%
Revenue Next 5Y9.48%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A